Latest | F'cast | |
---|---|---|
Div Yield | 0.0% | 0.0% |
Div Cover | n/a | n/a |
Op Mrgn | n/a | n/a |
ROCE | n/a |
Latest | F'cast | |
---|---|---|
P/E | n/a | n/a |
PEG | n/a | n/a |
Pr/Revenue | n/a | n/a |
Pr/Book | n/a |
Latest | F'cast | |
---|---|---|
Revenue | n/a | n/a |
PBT | n/a | n/a |
EPS | n/a | n/a |
DPS | n/a | n/a |
Fundamentals data is not available for this company.
Grant of performance share awards under LTIP | 17-Dec-2024 | 12:00 | RNS |
Enrolment Commences for VLU Clinical Trial | 16-Dec-2024 | 07:00 | RNS |
5 Year Veterans Administration Contract Extension | 12-Dec-2024 | 07:00 | RNS |
No recent information was found.
No deals were found in the last 28 days.
Currency | UK Pounds |
Share Price | 111.00p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 136.00 |
52 Week Low | 110.00 |
Volume | 5,455 |
Shares Issued | 106.36m |
Market Cap | £118.06m |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
08:49 | 5,455 @ 110.00p |
CEO | Michael Stephen Griffiths |
COO | Anthony Matthew Moffatt |
CFO | Jayesh Pankhania |
You are here: research